Abstract
Purpose of Review
An unconfirmed penicillin allergy is known to confer significant risk to patients. Only a small minority of patients labeled with penicillin allergy will be confirmed to be hypersensitive with the current reference standard test, an oral amoxicillin therapeutic dose challenge. Skin testing has been recommended prior to oral challenges to reduce the risk of severe acute challenge reactions. The rate of severe acute anaphylactic reactions with oral amoxicillin is currently extremely low. Unfortunately, penicillin skin testing, as commonly performed, has a high rate of false positive results.
Recent Findings
Encouraging skin testing in all individuals with an unconfirmed penicillin allergy, prior to a confirmatory oral challenge, would be technically difficult, make testing all individuals with an unconfirmed penicillin allergy very unlikely, and ultimately increase the risk to patients because of suboptimal antibiotic use. Most patients, who are appropriate candidates for a direct oral amoxicillin challenge, to confirm current penicillin tolerance, can be safely identified by their clinical histories. Higher risk individuals, those with a history of anaphylaxis or other acute onset potentially IgE-mediated reaction such as hives within 6 h of the first dose of the last course of a penicillin, may benefit from properly performed puncture and intradermal skin testing, using commercially available penicilloyl-polylysine, prior to an oral challenge, if skin test negative.
Summary
Direct oral amoxicillin challenges in low-risk individuals are well accepted by patients and a safe and effective part of penicillin allergy delabeling.
Similar content being viewed by others
Abbreviations
- ABIM:
-
American Board of Internal Medicine
- ASP:
-
Antibiotic stewardship program
- Cdiff:
-
Clostridiodes difficile
- ED:
-
Emergency Department
- FDA:
-
US Food and Drug Administration
- KPSC:
-
Kaiser Permanente Southern California
- MSSA:
-
Methicillin-sensitive Staphylococcus aureus
- OC:
-
Oral challenge
- SCAR:
-
Serious cutaneous adverse reaction
- ST:
-
Skin testing
- VRE:
-
Vancomycin-resistant Enterococcus
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Joint Task Force on Practice Parameters. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105:259–73.
Macy E, Ngoc JH. Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management. Ann Allergy Asthma Immunol. 2012;108:88–93.
•• Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. JAMA. 2019;321:188–99. An up-to-date review of penicillin allergy delabeling sponsored by the AAAAI, IDSA, and SHEA.
Macy E, Vyles D. Who needs penicillin allergy testing? Ann Allergy Asthma Immunol. 2018;121:523–9.
Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenge are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy. 2008;38:185–90.
• Macy E, Shu YH. The effect of penicillin allergy testing on future health care utilization: a matched cohort study. J Allergy Clin Immunol Pract. 2017;5:705–10. The largest prospective evaluation of the long-term benefits of penicillin allergy delabeling.
Blumenthal KG, Lu N, Zhang Y, Li Y, Walensky RP, Choi HK. Risk of methicillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ. 2018;361:k2400.
• Macy E, Contreras R. Healthcare utilization and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014;133:790–6. The first large study to show serious morbidity associated with an unconfirmed penicillin allergy in large population-based hospitalized cohort.
Torres MJ, Adkinson NF Jr, Caubet JC, Khan DA, Kidon MI, Mendelson L, et al. Controversies in drug allergy: beta-lactam hypersensitivity testing. AAAAI/WAO 2018 Symposium Penicillin and Cephalosporin Allergy Testing Working Group. J Allergy Clin Immunol Pract. 2019;7:40–5.
Moral L, Caubet JC. Oral challenges without skin tests in children with non-severe beta-lactam hypersensitivity. Pediatr Allergy Immunol. 2017;28:724–7.
Aberer W, Macy E. Moving toward optimizing testing for penicillin allergy. J Allergy Clin Immunol Pract. 2017;5:684–5.
Grossman CM. The first use of penicillin in the United States. Ann Intern Med. 2008;149:135–6.
Suchecki AI. Allergic reactions to penicillin. Br Med J. 1946;2(4485):938–40.
Green GR, Rosenblum AH, Sweet LC. Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prosepective study of the penicillin study group of the American Academy of Allergy. J Allergy Clin Immunol. 1977;60:339–45.
Sogn DD, Evans R 3rd, Shepherd GM, Casale TB, Condemi J, Greenberger PA, et al. Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med. 1992;152:1025–32.
Macy E, Richter PK, Falkoff R, Zeiger R. Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents. J Allergy Clin Immunol. 1997;100:586–91.
Blanca M, Mayorga C, Torres MJ, Reche M, Moyo MC, Rodriguez JL, et al. Clinical evaluation of Pharmacia CAP system RAST FEIA amoxicilloyl and benzypenicilloyl in patient with penicillin allergy. Allergy. 2001;56:862–70.
Zidam M, Silar M, Vegnuti M, Korosec P, Kosnik M. The specificity of tests for anti-beta-lactam IgE antibodies declines progressively with increase of total serum IgE. Wien Klin Wochensher. 2009;121:353–6.
Macy E, Goldberg B, Poon KWT. Use of commercial anti-penicillin-IgE FEIAs to diagnose penicillin allergy. Ann Allergy Asthma Immunol. 2010;105:136–41.
Blumenthal KG, Park MA, Macy EM. Redesigning the allergy module of the electronic health record. Ann Allergy Asthma Immunol. 2016;117:126–31.
Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. J Antimicrob Chemother. 2007;60:1172–9.
Macy E, Schatz M, Lin CK, Poon KW. The falling rate of positive penicillin skin tests from 1995 to 2007. Perm J. 2009;13:12–9.
https://www.penallergytest.com/wp-content/uploads/PRE-PEN-Package-Insert.pdf (accessed 1-22-2019).
Park MA, Matrsic D, Markus PJ, Li JT. Female sex as a risk factor for penicillin allergy. Ann Allergy Asthma Immunol. 2007;99:54–8.
Goldberg A, Confino-Cohen R. Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy. Ann Allergy Asthma Immunol. 2008;100:37–43.
Han J, Yi Y, Li C, Zhang Y, Wang L, Zhao Y, et al. Involvement of histamine and RhoA/ROCK in penicillin immediate hypersensitivity reactions. Sci Rep. 2016;6:33192. https://doi.org/10.1038/srep33192.
Tannert LK, Falkencrone S, Mortz C, et al. Is a positive intracutaneous test induced by penicillin mediated by histamine? A cutaneous microdialysis study in penicillin-allergic patients. Clin Transl Allergy. 2017;7:40. https://doi.org/10.1186/s13601-017-0179-2 eCollection 2017.
Ibanez MD, Del Rio PR, Lasa EM, et al. Prospective assessment of diagnostic tests for pediatric penicillin allergy, from clinical history to challenge tests. Ann Allergy Asthma Immunol. 2018;121:235–244.e3.
Mawhirt SL, Fonacier LS, Calixte R, Davis-Lorton M, Aquino MR. Skin testing and drug challenge outcomes in antibiotic-allergic patients with immediate-type hypersensitivity. Ann Allergy Asthma Immunol. 2017;118:73–9.
Lee RU, Banks TA, Waibel KH, Rodriguez RG. Penicillin allergy…maybe not? The military relevance for testing and delabeling. Mil Med. 2018. https://doi.org/10.1093/milmed/usy194.
Vyles D, Adams J, Chiu A, Simpson P, Nimmer M, Brousseau DC. Allergy testing in children with low-risk penicillin allergy symptoms. Pediatrics. 2017;140:e20170471.
Bourke J, Pavlos R, James I, Phillips E. Improving the effectiveness of penicillin allergy de-labeling. J Allergy Clin Immunol Pract. 2015;3:365–374.e1.
Confino-Cohen R, Rosman Y, Goldberg A, et al. Oral challenge without skin testing safely excludes clinically significant delayed-onset penicillin hypersensitivity. J Allergy Clin Immunol Pract. 2017;5:669–75.
Labrosse R, Paradis L, Lacombe J, et al. Efficacy and safety of 5-day challenge for the evaluation of nonsevere amoxicillin allergy in children. J Allergy Clin Immunol Pract. 2018;6:1673–80.
• Mill C, Primeau MN, Medoff E, et al. Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr. 2016;170:e160033. Comment: The first large population-based trial of direct oral challenges in children for penicillin allergy delabeling.
Iammatteo M, Alvarez A, Ferastraoaru D, et al. Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing. J Allergy Clin Immunol Pract. 2019;7:236–43.
Tucker MH, Lomas CM, Ramchandar N, Waldram JD. Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits. J Allergy Clin Immunol Pract. 2017;5:813–5.
Solensky R, Earl HS, Gruchalla RS. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med. 2002;162:822–6.
Macy E, Ho N. Adverse reactions associated with therapeutic antibiotic use after penicillin skin testing. Perm J. 2011;15:31–7.
Macy E, Mangat R, Burchette RJ. Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol. 2003;111:1111–5.
Lindsey D, Banks TA. Efficient identification and clearance of low-risk penicillin allergy patients. Oral presentation at the annual meeting of the American College of Allergy, Asthma & Immunology, November 19, 2018.
Banks TA, Ressner R, Gada SM. Antibiotic reclamation: penicillin allergy, antibiotic stewardship, and the allergist. Ann Allergy Asthma Immunol. 2015;115:451–2.
Rimawi RH, Cook PP, Gooch M, Kabchi B, Ashraf MS, Rimawi BH, et al. The impact of penicillin skin testing on clinical practice and antibiotic stewardship. J Hosp Med. 2013;8:341–5.
Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Kibicho J, et al. Antibiotic use after removal of penicillin allergy label. Pediatrics. 2018;141:e20173466.
Gerace KS, Phillips E. Penicillin allergy label persists despite negative testing. J Allergy Clin Immunol Pract. 2015;3:815–6.
Lachover-Roth I, Sharon S, Rosman Y, Meir-Shafrir K, Confino-Cohen R. Long-term follow-up after penicillin allergy delabeling in ambulatory patients. J Allergy Clin Immunol Pract. 2019;7:231–235.e1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Conflict of Interest
EM is a partner in the Southern California Permanente Medical Group. EM has received research support from the Southern California Permanente Medical Group, grants from ALK Abello, Inc. to study adverse drug reactions, and has served on clinical trial safety and monitoring committees for BioMarin, Ultragenyx, and Audentes.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Anaphylaxis and Drug Allergy
Rights and permissions
About this article
Cite this article
Banks, T.A., Tucker, M. & Macy, E. Evaluating Penicillin Allergies Without Skin Testing. Curr Allergy Asthma Rep 19, 27 (2019). https://doi.org/10.1007/s11882-019-0854-6
Published:
DOI: https://doi.org/10.1007/s11882-019-0854-6